4-butyrolactone has been researched along with Hepatic Insufficiency in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coppa, GF; Corbo, L; Idrovo, JP; Jacob, A; Nicastro, J; Wang, P; Yang, WL | 1 |
1 other study(ies) available for 4-butyrolactone and Hepatic Insufficiency
Article | Year |
---|---|
Inhibition of lipogenesis reduces inflammation andĀ organ injury in sepsis.
Topics: 4-Butyrolactone; Animals; Biomarkers; Enzyme Inhibitors; Hepatic Insufficiency; Inflammation; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Sepsis; Treatment Outcome | 2016 |